SEC Form 4 filing activity
Outlook Therapeutics, Inc. (OTLK)
Code-P purchase filings sourced directly from SEC EDGAR. No predictions, no scores — just what was filed.
ClusterSignal displays factual data from public SEC filings. This is not investment advice and does not constitute a recommendation to buy or sell any security.
Individual purchases
Insider purchase detected2026-07-29
Sukhtian Faisal Ghiath (Director) — 95,398 sh @ $1.05
Full filing history
| Date | Insider | Shares | Price | Notes |
|---|---|---|---|---|
| 2026-07-29 | Sukhtian Faisal GhiathDirector | 95,398 sh | @ $1.05 | — |